TADALAFIL
TADALAFIL
Approved
DIN Number
02536684
Drug Class
Human
Market Date
Aug 29, 2024
Company
HC
sivem pharmaceuticals ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02536684
AIG Number0149485004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BE08 TADALAFIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:12.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
TADALAFILActive
Strength: 5 MG
Monograph: TADALAFIL